SARAH CUBAS: Open Payments
NPI 1639803604 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 13 payments from 6 companies in 2025. Trend: 2023 $604 · 2024 $395 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Travere Therapeutics, Inc. | 4 | $53 |
| Fresenius USA Marketing, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Vifor Pharma, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Fabhalta, VELPHORO, JARDIANCE, Vanrafia, Veltassa, JYNARQUE.
Industry payments across GA — which companies pay providers there.
